Remgro and Investment Holding Limited (IHL) have signed an implementation agreement to restructure their shared interests in Mediclinic Holdings. The move would split the combined group along geographic lines. Remgro would become the sole owner of Mediclinic Southern Africa (MCSA). IHL would take 100% of Hirslanden, Mediclinic’s Swiss business. Remgro, chaired by Johann Rupert, and IHL currently each hold 50%…
Tag: M&A
-
AfroCentric’s JSE Collapse Fuels a New Healthcare Empire
As insurance giant Sanlam tightens its grip on health-fin services specialist AfroCentric, the line between public company and private control has all but vanished. What remains is a powerful lesson in strategic patience. It reveals how corporations (or businesses) can methodically turn market neglect into a corporate opportunity. While AfroCentric still technically trades on the JSE, its story is no…
-
Adcock Ingram Delisting After Natco Acquisition
Pharmaceutical giant Adcock Ingram has confirmed its delisting from the Johannesburg Stock Exchange (JSE) on 11 November 2025. The move marks the end of its 17-year run as a public company. This follows the finalisation of a R4.2 billion acquisition scheme by the Indian-based Natco Pharma. The company announced that it had fulfilled or waived all conditions precedent for the…